Pentoxifylline Tablet, Extended Release
Product Images NDC 0904-5448

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 0904-5448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of pentoxifylline showing its molecular arrangement with nitrogen, oxygen, and carbon atoms including methyl and propyl functional groups.*
FDA Label Image

400mg Carton Label (E67bdb49 8c37 8b4f C982 67d024d3f2aa 00)

400mg Carton Label (E67bdb49 8c37 8b4f C982 67d024d3f2aa 00)
Pentoxifylline Extended-Release 400 mg tablets by Major Pharmaceuticals, presented in a unit dose carton containing 100 tablets (10 x 10). The label includes dosage form as extended-release tablets, prescription only. Storage instructions indicate to keep between 20° to 25°C. The package is intended for institutional use, with warnings to keep out of reach of children and to dispense in a tight, light-resistant container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.